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Several 3-alkylaryl mimics of the enol intermediate in the reaction catalyzed by type II dehydroquinase 
were synthesized to investigate the effect in the inhibition potency of replacing the oxygen atom in the 
side chain by a carbon atom. The length and the ridigity of the spacer was also studied. The inhibitory 
properties of the resported compounds against type II dehydroquinase from Mycobacterium tuberculosis 10 
and Helicobacter pylori are also reported. The binding modes of these analogs in the active site of both 
enzymes were studied by molecular docking using GOLD 5.0 and dynamic simulations studies. 
Introduction 
In recent years, we have been working on the development of 
new antibiotics for the treatment of bacterial infections,[1] by 15 
inhibition of type II dehydroquinase (DHQ2), which catalyzes the 
reversible dehydration of 3-dehydroquinic acid (1) to form 3-
dehydroshikimic acid (2) (Scheme 1).[2,3] The reaction proceeds 
through an enol intermediate 3, which is stabilized by a 
conserved water molecule that interacts through hydrogen 20 
bonding to Asn12, the carbonyl group of Pro11, and the main-
chain amide of Gly78. The final step is the acid-catalyzed 
elimination of the C-1 hydroxyl group – a reaction mediated by a 
histidine residue, which acts as a proton donor.[4] 
 25 
Scheme 1. Enzymatic conversion of 3-dehydroquinic acid (1) to 3-dehydroshikimic 
acid (2) catalyzed by DHQ2. The reaction proceeds via an enol intermediate 3. 
Relevant residues are indicated (the numbering corresponds to M. tuberculosis). 
 
 In particular, we have focused on the inhibition of two 30 
pathogenic bacteria, Mycobacterium tuberculosis, the causative 
agent of tuberculosis and Helicobacter pylori, the causative agent 
of gastric and duodenal ulcers, which has also been classified as a 
type I carcinogen. We recently showed that 3-methoxyaryl 
derivatives 4ac (Figure 1), in which the aryl moiety is linked to 35 
the cyclohexene core by a methoxy group, are potent competitive 
inhibitors of DHQ2 from Helicobacter pylori (DHQ2-Hp) and 
Mycobacterium tuberculosis (DHQ2-Mt).[5] 
 
Figure 1. Selected examples of 3-methoxyaryl derivatives that are DHQ2 40 
competitive inhibitors. Inhibition constants against DHQ2-Mt are indicated. 
 
 The crystal structures of DHQ2-Hp and DHQ2-Mt in complex 
with compound 4c have been solved at 2.95 Å and 1.5 Å, 
respectively (Figure 2).[5,6] These crystal structures clarified the 45 
role of the aromatic rings on C3, which block the entrance of the 
essential arginine side chain into the active site and cause an 
important change in the conformation and flexibility of the loop 
that closes over the substrate binding site. Molecular dynamics 
simulation studies suggest that the aromatic ring prevents 50 
appropriate orientation of the catalytic tyrosine of the loop for 
proton abstraction and disrupts its basicity.[7] The crystal structure 
solved at 1.5 Å shows that the oxygen atom of the methylenoxy 
spacer of the inhibitor 4c is located 3.1 Å away from the 
conserved water molecule involved in the catalysis (Figure 2b). 55 
We assume that an important contribution of the high potency of 
the inhibitor, with Ki values of 42 nM
[5b]  and 130 nM[5a]  against 
DHQ2-Mt and DHQ2-Hp, respectively, is due to the hydrogen-
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bonding interaction between the oxygen atom of the methylenoxy 
spacer with the conserved water molecule. In order to corroborate 
this hypothesis, we decided to investigate the effect in the 
inhibition potency of replacing the oxygen atom in the side chain 
of 4ab by a carbon atom. In addition, the length and the rigidity 5 
of the alkylene spacer was also studied. To this end, 3-alkylaryl 
enol mimics 5, 6 and 7, having a vinylene, ethylene and 
propylene spacer, respectively, were designed (Figure 3). The 
results of inhibition studies of these compounds against DHQ2-
Mt and DHQ2-Hp, docking studies using GOLD 5.0 and dynamic 10 
simulations studies are also described.  
 
 
Figure 2. Selected views of the crystal structures of the binary complex of: a) 
DHQ2-Hp/4c (PDB: 2WKS, 2.95 Å)[5a]; b) DHQ2-Mt/4c (PDB: 2Y71, 1.5 Å)[5b]. 15 
Relevant residues are indicated. 
Results and Discussion 
Synthesis of vinylene derivatives 5 
The synthesis of the target compounds 5 was achieved by Suzuki 
cross-coupling reactions between our previously reported vinyl 20 
triflate 12[2c] and the appropriate boronic acid pinacol esters 11 
(Scheme 2). Firstly, the Sonogashira cross-coupling reaction of 
commercially available aryl bromides 8 with 
trimethylsilylacetylene gave the protected alkynes 9, which by 
deprotection with TBAF afforded terminal alkynes 10 (Scheme 2 25 
and Table 1). Finally, hydroboration of alkynes 10 with catechol 
borane gave the required boronic acid pinacol esters 11 in good 
yield. Suzuki cross-coupling between vinyl triflate 12[2c] and 
boronic acid pinacol esters 11 gave the corresponding cross-
coupling products 13, which were converted to the desired acids 30 
5 by deprotection followed by basic hydrolysis of the 
corresponding lactones 14 and protonation with an ion-exchange 
resin. 
 
Figure 3. Target compounds 35 
 
Scheme 2. Synthesis of compounds 5. Reagents and conditions: a) HCCTMS, CuI, 
Pd(PPh3)2Cl2, Et3N, 40 ºC; b) TBAF, THF, RT; c) 1. Catechol borane, THF, ; 2. 
Pinacol, THF, ; d) Pd(PPh3)4, K3PO4 (aq.), dioxane, 80 ºC; e) 1. LiOH, THF, RT; 
2. Amberlite IR-120 (H+). 40 
 
Table 1. Synthesis of compounds 9-11, 13, 14 and 5.a 
Reaction Comp Yield (%) Comp Yield (%) 
89 9a 99 9b 98 
910 10a 98 10b 87 
1011 11a 85 11b 94 
1213 13a 94 13b 87 
1314 14a 65 14b 43 
145 5a 77 5b 79 
aa Ar = naphth-2-yl; b Ar = benzo[b]thiophen-2-yl. 
 
Synthesis of ethylene derivatives 6 45 
The synthesis of ethylene side-chain acids 6 was first addressed 
by selective reduction of the external double bond in dienes 13 
(Scheme 3 and Table 2). Catalytic hydrogenation of 13 using 
Rosemund’s catalyst gave the desired saturated derivatives 15a 
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and 15b in 75% and 56% yield, respectively. Surprisingly, the 
reduction of naphthyl derivative 13a also afforded a 20% yield of 
compound 15c resulting from a partial reduction of the naphthyl 
moiety. However, this side reduction was avoided by using 
Raney-Ni as catalyst to afford compound 15a as a single product 5 
in 78% yield. The tetrahydronaphthyl derivative 15c was also 
transformed into its corresponding acid 6c to test its biological 
activity. 
 
Scheme 3. Synthesis of acids 6. Reagents and conditions: a) H2, Rosemund’s 10 
catalyst, 50% THF/MeOH, RT; b) H2, Raney-Ni, 50% THF/MeOH, RT; c) 
PdCl2(dppf), K3PO4, THF, ; d) TBAF, THF, RT; e) 1. LiOH, THF, RT; 2. 
Amberlite IR-120 (H+); f) vinyl boronic acid pinacol ester, Pd(PPh3)4, K3PO4 (aq.), 
dioxane, 80 ºC; g) 9-BBN-H, THF, 0 ºC to RT. 
 15 
Table 2. Synthesis of compounds 15-18 and 6.a 
Reaction Comp Yield  
(%) 




1315 15a 75 15b 56 15c 20 
13a15 15a 78 -- -- 15c 0 
1215 15a 80 15b 80 -- -- 
1516 16a 79 16b 60 16c 90 
166 6a 85 6b 83 6c 85 
8b17b -- -- 17b 96 -- -- 
aa Ar = naphth-2-yl; b Ar = benzo[b]thiophen-2-yl; c Ar = 5,6,7,8-tetrahydronaphth-
2-yl. 
 
 The selective reduction of dienes 15 proved to be 20 
experimentally problematical due to the difficulty in controlling 
and monitoring the reduction. Because of that, we were 
particularly interested in addressing the synthesis of the alkyl 
lactones 15 by a direct sp3sp2 cross-coupling reaction. After 
numerous attempts using various sp3 boronic acids or their 25 
corresponding boronic acids pinacol esters, the cross-coupling 
was achieved by using alkyl boranes 18 and PdCl2(dppf) as 
catalyst in the presence of K3PO4 in THF.
[8] Alkyl boranes 18 
were synthesized by hydroboration with 9-BBN-H of vinyl 
derivatives 17. Non-commercially available vinyl derivative 17b 30 
was prepared by Suzuki cross-coupling of halide 8b and vinyl 
boronic acid pinacol ester. Finally, compounds 15 were converted 
to the desired acids 6 in the same way as acids 5 from lactones 
13. 
 35 
Synthesis of propylene derivatives 7 
 Our initial attempts to synthesize compounds 7 involved as the 
key step the Sonogashira cross-coupling between the triflate 12[2c] 
and the terminal alkynes 20, followed by selective reduction of 
the resulting enynes (Scheme 4 and Table 3). The required 40 
alkynes 20 were prepared by treatment of the Grignard derivative 
of 8 with (3-bromoprop-2-ynyl)trimethylsilane followed by 
deprotection. The latter reaction was achieved by treatment with 
AgNO3 in ethanol as the usual TBAF or MeOH/K2CO3 
conditions afforded allenes 21 in good yield. 45 
 
Scheme 4. Synthesis of compounds 7. Reagents and conditions: a) 1) Mg, I2 (cat), 
THF, . 2) TMSCCCH2Br; b) K2CO3, MeOH, 0 ºC to RT; c) AgNO3, EtOH (aq), 
RT; d) 1) Mg, I2 (cat), THF, . 2) AllylBr; e) 9-BBN-H, THF, 0 ºC to RT; f) 
Pd(PPh3)4, piperidine, CuI, THF, 40 ºC; g) H2, Rosemund’s catalyst, 50% 50 
THF/MeOH, RT; h) PdCl2(dppf), K3PO4, THF, ; i) TBAF, THF, RT; j) 1. LiOH, 
THF, RT; 2. Amberlite IR-120 (H+). 
 
Table 3. Synthesis of compounds 19-26 and 7.a 
Reaction Comp Yield (%) Comp Yield (%) 
819 19a 54 19d 69 
19a21a 21a 91 -- -- 
1920 20a 72 20d 61 
822 22a 99 22d 89 
1224 24a 98 24d 95 
2425 25a 98 25d 98 
1225 25a 70 25d 42 
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2526 26a 77 26d 67 
267 7a 94 7d 87 
aa Ar = naphth-2-yl; d Ar = benzo[b]thiophen-3-yl. 
 
Sonogashira cross-coupling reaction between terminal alkynes 20 
and triflate 12[2c] in the presence of piperidine, a catalytic amount 
of copper iodide and Pd(PPh3)4 catalyst provided an excellent 5 
yield of the cross-coupling products 24. The selective reduction 
of enynes 24 by catalytic hydrogenation using Rosemund’s 
catalyst gave saturated side chain derivatives 25 in excellent 
yield. Alternatively, alkyl compounds 25 were synthesized by B-
alkyl Suzuki cross-coupling between triflate 12[2c] and alkyl 10 
boranes 23 using Pd(PPh3)4 as catalyst and in the presence of 
K3PO4. Alkyl boranes 23 were prepared by reaction of the 
Grignard derivative of 8 with allyl bromide followed by 
hydroboration with 9-BBN-H of the corresponding allyl 
derivative 22. Finally, compounds 25 were converted to the 15 
desired acids 7 in the same way as acids 5 from lactones 13. 
 
Inhibition Assay Results 
The inhibitory properties of compounds 57 against DHQ2-Hp 
and DHQ2-Mt were tested. These compounds proved to be 20 
reversible competitive inhibitors of both enzymes. The inhibition 
data (Ki) are summarised in Table 4. 
 
Table 4. Ki (nM) values for compounds 57 against DHQ2-Hp and DHQ2-Mt. 
Entry Comp R H. pylori[a] M. tuberculosis[b] 
1 5a (E)CH=CH 1400 ± 98 780 ± 94 
2 5b (E)CH=CH 3110 ± 249 520 ± 31 
3 6a (CH2)2 790 ± 29 436 ± 13 
4 6b (CH2)2 2460 ± 197 254 ± 20 
5 6c (CH2)2 1150 ± 115 274 ± 16 
6 7a (CH2)3 243 ± 19 180 ± 9 
7 7d (CH2)3 295 ± 10 73 ± 4 
8 4a OCH2 310 ± 46
[5b] 35 ± 2[5b] 
9 4b OCH2 132 ± 13
[5a] 28 ± 2[5b] 
[a] Assay conditions: pH 7.0, 25 ºC, 50 mM Tris.HCl. [b] Assay conditions: pH 
7.0, 25 ºC, 50 mM Tris.HOAc. 
  
The biological results show that, in general, the effects of type, 25 
geometry and size of spacer were more pronounced in the 
inhibition potency against the DHQ2-Hp enzyme and in all cases 
the propylene spacer was the most potent of the series for both 
enzymes. In general, compounds 6 and 7 having a flexible spacer 
proved to be more potent than compounds 5 with a more rigid 30 
one (Table 4, entry 6 vs 1). Benzothiophene 7d having a 
propylene spacer was the most potent compound in the series, 
with Ki values of 73 nM and 295 nM against DHQ2-Mt and 
DHQ2-Hp, respectively. Naphthyl derivative 7a also showed a 
high affinity against both enzymes, with Ki values of 180 nM and 35 
243 nM against DHQ2-Mt and DHQ2-Hp, respectively. In 
addition, tetrahydronaphathalene 6c proved to have binding 
affinities against DHQ2 in the same range as the other 
unsaturated analogs 6a–b (Table 4, entry 5 vs 3). In order to get 
an insight of the binding mode of these inhibitors, docking 40 
studies using GOLD 5.0.1[9] were carried out, which are 
discussed below. 
 
Docking studies  
The binding modes of inhibitors 57 with DHQ2 enzymes were 45 
studied using GOLD 5.0.1[9] with the enzyme geometries found 
in crystals of DHQ2-Hp and DHQ2-Mt binding to 3-methoxyaryl 
derivative 4c (PDB code: 2WKS[5a] and 2Y71,[5b] respectively). 
 In general, 3-alkylaryl enol mimics with a three-carbon-atom 
spacer, as in ligands 7, fit more efficiently into the active site than 50 
the corresponding ethylene ones (ligands 6) because they locate 
the aromatic ring closer to the aliphatic residues of the enzyme 
active site (leucine pocket). This fact may account for the higher 
inhibition potency of propylene derivatives 7 relative to inhibitors 
5 and 6. The GOLD-predicted binding mode of one of the most 55 
active ligands of the 3-alkylaryl series, compound 7d, in the 
active site of both enzymes is shown in Figure 4. These docking 
studies show that this inhibitor should have similar polar 
interactions, through hydroxyl and carboxylate groups (not 
shown), to other mimetics of the enol intermediate, such as the 60 
ones present in the previously reported crystal structures (PDB 
code: 2WKS[5a] and 2Y71[5b]), because the cyclohexene ring 
occupies approximately the same position in the active site. More 
importantly, in both cases, the benzothiophene ring and the 
spacer are involved in a set of strong lipophilic interactions in this 65 
part of the active site. The benzothiophene moiety interacts with 
the essential tyrosine by π stacking in DHQ2-Hp (Tyr22, Figure 
4a) and by an edge-face π-π interaction in DHQ2-Mt (Tyr24, 
Figure 4b). This aromatic ring is also in close contact with the 
side chain of Leu14 and the five-membered ring of Pro19 in 70 
DHQ2-Hp and the side chain of Leu16, the carbon side chain of 
Arg15 and the essential Arg19 in DHQ2-Mt. The latter residues 
are located in the flexible loop that closes over the substrate 
binding site. The benzothiophene ring also interacts with some 
residues of a symmetry-related neighboring molecule 75 
(specifically, the side chains of Leu93, Met92 and Asp89 for 
DHQ2-Hp and the side chains of Ala91, Glu92 and Asp88 for 
DHQ2-Mt). The propylene moiety of 7d interacts with the side 
chain of Leu11/Leu14, the carbon side chain of Asn10/Asn12 and 
carbon main chain of Gly78/Gly77 for DHQ2-Hp and DHQ2-Mt, 80 
respectively. 
 Comparison of saturated ligands 6 and the unsaturated ones 5 
reveals that the saturated ones are predicted to be far more active 
than the corresponding unsaturated derivatives 5, because the 
chain flexibility allows it to accommodate more adequately the 85 
aromatic ring in the active site, thus maximizing interactions 
(Figure 5). In fact, the GOLD-predicted binding mode of ligand 
5a shows that the cyclohexene moiety is moved away from the 
polar contacts of the active site that anchors the six-membered 
ring of the substrate and the enol intermediate in the active site, 90 
i.e. His82, His101, etc. (Figure 5). Even assuming that in a 
dynamic process the loop conformation and/or side chain residues 
might change, the ethylene spacer seems more suitable to 
maintain the polar interactions that anchor the cyclohexene 
moiety of the inhibitor. 95 
 




Figure 4. GOLD-predicted binding for ligand 7d to the active site of: a) DHQ2-Hp 
(PDB: 2WKS[5a]); b) DHQ2-Mt (PDB: 2Y71[5b]). Relevant residues are indicated. 5 
Symmetry-related neighboring chain close to the active site is indicated in gray. 
 
Molecular Dynamics Simulations 
On the other hand, the inhibition data clearly show that the 
replacement of the oxygen atom of the methylenoxy spacer by a 10 
carbon atom affords less potent inhibitors. This fact suggests that 
the oxygen atom of the spacer in compounds 4 is involved in a 
strong binding interaction with the essential water involved in the 
enzymatic mechanism, as described below. As shown in the 
recently solved crystal structure of the binary complex DHQ2-15 
Mt/4c, the oxygen atom of the spacer is located 3.1 Å away from 
the essential water molecule (Figure 2b). Therefore, this 
interaction should be lost on replacing the ether linkage by a 
methylene group. In order to corroborate this hypothesis and 
further analyze the binding mode of these inhibitors in the active 20 
site of the DHQ2, we studied the binding mode of O-alkylaryl 
derivative 4c and the corresponding C-alkylaryl derivative 6e (Ar 
= 5-methylbenzo[b]thiophen-3-yl) by molecular dynamics 
simulations (MD). The results show that the position in the active 
site of 3-methoxybenzothiophenyl derivatives 4c, which has a 25 
methylenoxy spacer, does not change significantly during the 
simulation (10 ns) – including its position relative to the catalytic 
water (Figures 6ab). 
 
Figure 5. Comparison of the position of inhibitor 4c (green) in the enzymeinhibitor 30 
crystal structure of DHQ2-Hp (PDB code: 2WKS[5a]) with the docking results of the 
highest score solution of ligands: 5a (pale orange) and 6a (blue). Relevant residues 
are indicated. The hydrogen bonding interactions of hydroxyl groups on C-1 and C-5 
with His82 and His102 are highlighted as dotted lines with the same color as the 
corresponding ligand. Note how these contacts are much weaker for ligand 5a than 35 
for compounds 6a and 4c. 
 
 For 3-ethylbenzothiophenyl ligand 6e, which contains an 
ethylene spacer, relevant changes were not found in the position 
of the cyclohexene moiety and therefore its polar contacts 40 
through hydroxyl and carboxylate groups with residues of the 
active site [His80, Arg111, Ser102, Asn74, His100, Asp89 
(neighboring unit)]. However, an important change in the position 
and conformation of the side chain and the aromatic ring was 
observed. Both moieties are shifted significantly after the 45 
simulation, which causes a change in the position of the loop 
because the volume occupied by the ligand 6e is now greater. As 
shown in Figure 6, while the distance between the oxygen atom 
of the methylenoxy spacer in ligand 4c does not change 
significantly after 10 ns of simulation (from 3.1 Å to 2.8 Å), the 50 
corresponding distance for ligand 6e increases from 3.2 Å to 4.2 
Å (see also supporting information). Therefore, the substitution of 
the methylenoxy spacer by an alkylene one might cause the loss 
of a favorable polar interaction between the ligand and the 
catalytic water and this in turn causes a loss of inhibition potency. 55 
Conclusions 
Several 3-alkylaryl mimics of the enol intermediate in the 
reaction catalyzed by the third enzyme of the shikimic acid 
pathway, i.e. type II dehydroquinase – an essential enzyme in M. 
tuberculosis and H. pylori, were synthesized and tested as 60 
inhibitors of these enzymes. Vinylene derivatives 5 were 
synthesized by Suzuki cross-coupling reactions between 
previously reported triflate 12[2c] and boronic acids pinacol esters 
11 as key step. 2- and 3-alkylaryl enol mimics 6 and 7 were 
synthesized by B-alkyl Suzuki cross-coupling reactions using 65 
alkyl boranes 18 and 23, respectively. Ethylene 6 and propylene 
side-chain acids 7 were also synthesized by selective catalytic 
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hydrogenation using Rosemund´s catalyst or Raney-Ni of the 
external double and tripe bond in dienes 13 and enynes 24, 
respectively, which were obtained by Suzuki and Sonogashira 
cross-coupling reactions. 
 The reported compounds were synthesized to evaluate the 5 
contribution in the high potency of inhibitors 4 of the hydrogen-
bonding interaction between the oxygen atom of the methylenoxy 
spacer and the essential water involved in the catalysis, as well as 
the length and the rigidity of the alkylene spacer. The biological 
results show that the replacement of the oxygen atom of the 10 
methylenoxy spacer of previously reported inhibitors 4a[5a] and 
4c[5b] by a carbon atom leads to a decrease in the inhibition 
potency upto 20-fold. The inhibition data toghether with the 
molecular dynamics simulation studies performed show that this 
hydrogen-bonding interaction has an important contribution on 15 
the inhibition potency of inhibitors 4 and it should therefore be 
considered in future designs. In general, effects of geometry and 
size of the alkyl spacer were more pronounced in the inhibition 
potency against the DHQ2-Hp enzyme and in all cases 
compounds 6 and 7 having a flexible spacer proved to be more 20 
potent than compounds 5 with a more rigid one. Docking studies 
using the program GOLD 5.0.1 suggest that compounds with a 
three-carbon spacer fit more efficiently into the active site 
because they locate the aromatic ring closer to the aliphatic 




Figure 6. Binding mode of ligand 4c (cyan) and ligand 6e (green) in the active site of DHQ2-Mt obtained by MD simulations: a and c) after minimization and previously to 
simulation; b and d) after 10 ns of MD. Distance between the oxygen atom of the spacer of ligand 4c (O6), the corresponding carbon atom in ligand 6e (C8) and essential water 30 
molecule is indicated. Only relevant residues are indicated. 
Experimental 
General 
All starting materials and reagents were commercially available 
and were used without further purification. 1H NMR spectra (250, 35 
300, 400 and 500 MHz) and 13C NMR spectra (63, 75, 100 and 
125 MHz) were measured in deuterated solvents. J values are 
given in Hertz. NMR assignments were carried out by a 
combination of 1 D, COSY, and DEPT-135 experiments. FT-IR 
spectra were recorded as NaCl plates or KBr discs. []D20 =  40 
values are given in 10-1 deg cm2 g-1. All procedures involving the 
use of ion-exchange resins were carried out at room temperature 
using Milli-Q deionized water. Amberlite IR-120 (H+) (cation 
exchanger) was washed alternately with water, 10% NaOH, 
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water, 10% HCl, and finally water before use. HPLC was 
performed on a semipreparative column (Phenomenex Luna, 250 
× 21.2 mm, C18), eluting with acetonitrile-water at a flow rate of 
7 mL min–1. 
 5 
Trimethyl(3-(naphthalen-2-yl)ethynyl)silane (9a) 
A Shlenck tube was charged with 2-bromonaphthalene (8a) (500 
mg, 2.41 mmol), Pd(PPh3)2Cl2 (105 mg, 0.14 mmol), CuI (25 mg, 
0.14 mmol) and dry triethylamine (5 mL). The resulting solution 
was deoxygenated and ethynyltrimethylsilane (0.5 mL, 3.62 10 
mmol) was added dropwise. After addition of the first drop, the 
reaction color changed from yellow to black. The resulting 
solution was heated at 40 ºC for 5 h. After cooling to room 
temperature, saturated ammonium chloride (0.5 mL) was added 
and the reaction mixture was extracted with diethyl ether (×3). 15 
The combined organic extracts were dried (anh. Na2SO4), filtered 
and concentrated under reduced pressure. The residue obtained 
was purified by flash chromatography on silica gel, eluting with 
hexanes to give silane 9a (534 mg, 99%) as a brown oil. H (250 
MHz; CDCl3): 8.19 (1 H, br s, ArH), 7.907.83 (3 H, m, 3×ArH), 20 
7.70 (1 H, dd, J = 7.5 and 1.5 Hz, ArH), 7.56 (2 H, dd, J = 6.3 
and 3.2 Hz, 2×ArH) and 0.52 (9 H, s, 3×SiCH3); C (63 MHz; 
CDCl3): 133.0 (2×C), 132.1 (CH), 128.6 (CH), 128.0 (2×CH), 
127.8 (CH), 126.8 (CH), 126.6 (CH), 120.5 (C), 106.8 (C), 95.6 
(C) and 0.2 (3×SiCH3); max (film)/cm
-1 2152 (C≡C). 25 
 
(Benzo[b]thiophen-2-ylethynyl)trimethylsilane (9b) 
The experimental procedure used was the same as for alkyne 9a 
utilizing 2-bromobenzo[b]thiophene (8b) (1 g, 4.69 mmol). 
Yield= 1.05 g (98%). White solid. Mp: 5758 ºC; H (250 MHz; 30 
CDCl3): 7.817.75 (2 H, m, 2×ArH), 7.52 (1 H, br s, ArH), 
7.417.37 (2 H, m, 2×ArH) and 0.37 (9 H, s, 3×SiCH3); C (63 
MHz; CDCl3): 140.2 (C), 139.0 (C), 129.6 (CH), 125.6 (CH), 
124.8 (CH), 124.0 (CH), 123.2 (C), 122.1 (CH), 101.1 (C), 98.0 
(C), and 0.1 (3×SiCH3); max (KBr)/cm
-1 2143 (C≡C); MS (ESI) 35 
m/z 231 (MH+); HRMS (ESI) calcd for C13H15SSi (MH
+): 
231.0658, found 231.0666. 
 
2-Ethynylnaphthalene (10a) 
Tetrabutylammonium fluoride (2.9 mL, 2.87 mmol, ca 1.0 M in 40 
THF) was added to a stirred solution of the silyl ether 9a (534 
mg, 2.39 mmol) in dry THF (25 mL) under argon at room 
temperature. After stirring for 1 h the solvent was removed under 
reduced pressure and the residue was dissolved in ethyl acetate 
and HCl (10%). The organic layer was separated and the aqueous 45 
layer was extracted with ethyl acetate (×2). The combined 
organic extracts were dried (anh. Na2SO4), filtered and 
concentrated under reduced pressure. The residue was purified by 
flash chromatography on silica gel, eluting with hexanes to yield 
alkyne 10a (354 mg, 98%) as a colorless oil. H (250 MHz; 50 
CDCl3): 8.19 (1 H, s, ArH), 7.927.85 (3 H, m, 3×ArH), 7.71 (1 
H, dd, J = 8.5 and 1.6 Hz, ArH), 7.607.57 (2 H, m, ArH) and 
3.36 (1 H, s, CH); H (63 MHz; CDCl3): 133.0 (C), 132.8 (C), 
132.3 (CH), 128.5 (CH), 128.0 (CH), 127.7 (2×CH), 126.9 (CH), 





The experimental procedure used was the same as for 2-
ethynylnaphthalene (10a) utilizing silyl ether 9b (1.05 g, 4.58 60 
mmol). Yield = 630 mg (87%). Red Liquid. H (250 MHz; 
CDCl3): 7.847.78 (2 H, m, 2×ArH), 7.58 (1 H, s, ArH), 
7.457.41 (2 H, m, 2×ArH) and 3.53 (1 H, s, CH); C (63 MHz; 
CDCl3): 140.1 (C), 138.7 (C), 130.1 (CH), 125.8 (CH), 124.8 
(CH), 124.0 (CH), 122.0 (CH), 121.9 (C), 83.2 (C) and 77.3 65 
(CH); max (film)/cm




A Shlenck tube was charged with 2-ethynylnaphthalene (10a) 70 
(1.54 g, 10.14 mmol), catecholborane (1.28 mL, 11.15 mmol) and 
dry THF (2 mL). The resultant solution was heated under reflux 
for 12 h. After cooling to room temperature, a solution of pinacol 
(3.85 g, 32.57 mmol) in dry THF (20 mL) was added. The 
reaction mixture was heated under reflux for 19 h. After cooling 75 
to room temperature, the solvent was removed under reduced 
pressure. The residue was purified by flash chromatography on 
silica gel, preneutralized with (1:2:97) triethylamine/diethyl 
ether/hexanes, using (3:97) diethyl ether/hexanes as eluent, to 
give boronic acid pinacol ester 11a (2.43 g, 85%) as a yellow oil. 80 
H (250 MHz; CDCl3): 7.83 (4 H, m, 4×ArH), 7.61 (1 H, d, J = 
18.5 Hz, CH=CHB), 7.48 (3 H, m, 3xArH), 6.33 (1 H, d, J = 18.5 
Hz, CH=CHB), 1.36 (9 H, s, 3×CH3) and 1.24 (3 H, s, CH3); C 
(63 MHz; CDCl3): 149.5 (CH), 134.9 (C), 133.7 (C), 133.4 (C), 
128.4 (CH), 128.2 (CH), 128.0 (CH), 127.6 (2×CH), 126.4 (CH), 85 




1,3,2-dioxaborolane (11b) 90 
The experimental procedure used was the same as for 
dioxaborolane 11a utilizing alkyne 10b (600 mg, 3.79 mmol). 
Yield: 1.03 g (94%). Yellow oil. H (250 MHz; CDCl3): 
7.847.76 (2 H, m, 2×ArH), 7.69 (1 H, d, J = 18.0 Hz, 
CH=CHB), 7.357.32 (2 H, m, 2×ArH), 7.29 (1 H, s, ArH), 6.16 95 
(1 H, d, J = 18.0 Hz, CH=CHB) and 1.38 (12 H, s, 4×CH3); C 
(63 MHz; CDCl3): 143.8 (C), 142.3 (CH), 139.8 (C), 139.5 (C), 
125.2 (CH), 125.0 (CH), 124.4 (CH), 123.9 (2×CH), 122.2 (CH), 




A Shlenck tube was charged with triflate 12[2c] (57 mg, 0.11 
mmol), Pd(PPh3)4 (4.1 mg, 0.035 mmol) and dry dioxane (1 mL). 
K3PO4 (0.18 mL, 0.18 mmol, 1 M) and dioxaborolane 11a (60 105 
mg, 0.21 mmol) were added. The resultant solution was 
deoxygenated and heated at 80 ºC for 3.5 h under argon. After 
cooling to room temperature, the solvent was removed under 
reduced pressure. The residue was dissolved in a mixture of 
dichloromethane and water. The organic layer was separated and 110 
the aqueous phase was extracted with dichloromethane (×2). The 
combined organic extracts were dried (Na2SO4), filtered and 
concentrated under reduced pressure. The residue obtained was 
purified by flash chromatography on silica gel, eluting with a 
gradient of dichloromethane-hexanes (15:85 to 25:75), to give 115 
naphthyl derivative 13a (56 mg, 94%) as a white foam. []D20 =  –
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9.8º (c1.0 in CHCl3); H (250 MHz; CDCl3): 7.857.74 (4 H, m, 
4×ArH), 7.507.41 (3 H, m, 3×ArH), 6.89 (1 H, d, J = 16.3 Hz, 
ArCH=CH), 6.70 (1 H, d, J = 16.3 Hz, ArCH=CH), 6.18 (1 H, s, 
H-2), 4.66 (1 H, m, H-5), 4.58 (1 H, d, J = 3.2 Hz, H-4), 2.55 (1 
H, d, J = 10.6 Hz, H-6ax), 2.41 (1 H, m, H-6eq), 1.00 (9 H, s, 5 
C(CH3)3), 0.94 (9 H,
 s, C(CH3)3), 0.30 (3 H, s, SiCH3), 0.28 (3 H, 
s, SiCH3), 0.26 (3 H, s, SiCH3) and 0.24 (3 H, s, SiCH3); C (63 
MHz; CDCl3): 175.4 (C), 136.7 (C), 134.1 (C), 134.1 (CH), 133.7 
(C), 133.2 (C), 130.6 (CH), 128.5 (CH), 128.1 (CH), 127.8 (CH), 
126.8 (2×CH), 126.5 (CH), 126.2 (CH), 123.2 (CH), 83.2 (C), 10 
75.3 (CH), 66.2 (CH), 37.2 (CH2), 25.7 (2×C(CH3)3), 18.1 
(2×C(CH3)3), 2.9 (2×CH3), 3.9 (CH3) and 4.1 (CH3); max 
(film)/cm-1 1799 (CO) cm-1; MS (ESI) m/z = 559 (MNa+); 
HRMS (ESI) calcd for C31H44O4SiNa (MNa





The experimental procedure used was the same as for compound 
13a utilizing triflate 12[2c] (355 mg, 0.67 mmol) and 20 
dioxaborolane 11b (382 mg, 1.34 mmol). White foam. Yield = 
315 mg (87%). []D20 = –94.4º (c 1.0 in CHCl3); H (250 MHz; 
CDCl3): 7.867.76 (2 H, m, 2×ArH), 7.437.36 (2 H, m, 2×ArH), 
7.26 (1 H, s, ArH), 7.03 (1 H, d, J = 16.0 Hz, ArCH=CH), 6.54 (1 
H, d, J = 16.0 Hz, ArCH=CH), 6.26 (1 H, s, H-2), 4.73 (1 H, dd, J 25 
= 3.3 and 5.2 Hz, H-5), 4.58 (1 H, d, J = 3.3 Hz, H-4), 2.60 (1 H, 
d, J = 10.6 Hz, H-6ax), 2.552.42 (1 H, m, H-6eq), 1.08 (9 H, s, 
C(CH3)3), 1.03 (9 H,
 s, C(CH3)3), 0.38 (3 H, s, CH3), 0.36 (3 H, s, 
CH3), 0.33 (3 H, s, CH3) and 0.31 (3 H, s, CH3); C (63 MHz; 
CDCl3): 175.2 (C), 142.2 (C), 140.1 (C), 139.1 (C), 136.0 (C), 30 
134.5 (CH), 128.4 (CH), 125.0 (CH), 124.6 (C), 124.4 (CH), 
123.8 (CH), 123.6 (CH), 122.3 (CH), 75.8 (CH), 75.2 (C), 66.3 
(CH), 37.1 (CH2), 25.7 (2×C(CH3)3), 18.1 (2×C(CH3)3), 2.9 
(2×CH3), 3.9 (CH3) and 4.3 (CH3); max (film)/cm
-1 1799 
(CO); MS (ESI) m/z = 543 (MH+); HRMS (ESI) calcd for 35 
C29H43O4SSi2 (MH




The experimental procedure used was the same as for alkyne 9a 40 
utilizing silyl ether 13a (290 mg, 0.54 mmol). Purification by 
flash chromatography over silica gel, eluting with (1:1) ethyl 
acetate/hexanes gave diol 14a (107 mg, 65%) as a colorless oil. 
[]D20 = 95.7º (c 1.0 in MeOH); H (250 MHz; CD3OD): 7.80–
7.75 (4 H, m, 4×ArH), 7.64 (1 H, dd, J = 8.7 and 1.3 Hz, ArH), 45 
7.447.39 (2 H, m, 2×ArH), 7.11 (1 H, d, J = 16.4 Hz, 
ArCH=CH), 6.82 (1 H, d, J = 16.4 Hz, ArCH=CH), 6.16 (1 H, s, 
H-2), 4.73 (1 H, m, H-5), 4.54 (1 H, d, J = 3.2 Hz, H-4) and 
2.492.41 (2 H, m, CH2); C (63 MHz; CD3OD): 178.4 (C), 138.4 
(C), 135.8 (C), 135.1 (C), 134.8 (CH), 134.6 (C), 132.2 (CH), 50 
129.3 (CH), 129.0 (CH), 128.6 (CH), 128.3 (CH), 127.8 (CH), 
127.4 (CH), 127.1 (CH), 124.3 (CH), 78.0 (CH), 74.5 (C), 65.8 
(CH2) and 37.6 (CH2); max (film)/cm
-1 3381 (OH) and 1772 
(CO); MS (ESI) m/z = 331 (MNa+); HRMS (ESI) calcd for 
C19H16O4Na (MNa




The experimental procedure used was the same as for diol 14a 
utilizing silyl ether 13b (315 mg, 0.58 mmol). Yield = 79 mg 60 
(43%). []D20 = –82.4º (c 1.0 in MeOH); H (250 MHz; CD3OD): 
7.787.67 (2 H, m, 2×ArH), 7.317.17 (3 H, m, 3×ArH), 7.22 (1 
H, d, J = 16.0 Hz, ArCH=CH), 6.56 (1 H, d, J = 16.0 Hz, 
ArCH=CH), 6.14 (1 H, s, H-2), 4.71 (1 H, m, H-5), 4.49 (1 H, d, 
J = 3.3 Hz, H-4) and 2.442.35 (2 H, m, CH2); C (63 MHz; 65 
CD3OD): 178.2 (C), 143.7 (C), 141.6 (C), 140.4 (C), 138.0 (C), 
135.6 (CH), 129.9 (CH), 126.1 (2×CH), 125.7 (CH), 125.2 (CH), 
124.6 (CH), 123.1 (CH), 78.0 (CH), 74.5 (C), 65.8 (CH) and 37.6 
(CH2); max (film)/cm
-1 3427 (OH) and 1780 (CO); MS (ESI) m/z 
= 337 (MNa+); HRMS (ESI) calcd for C17H14O4SNa (MNa
+): 70 
337.0505, found 337.0494. 
 
(1R,4R,5R)-1,4,5-Trihydroxy-3-((E)-2-(naphth-2-
yl)vinyl)cyclohex-2-ene-1-carboxylic acid (5a) 
A solution of the lactone 14a (30 mg, 0.10 mmol) in THF (1 mL) 75 
and aqueous lithium hydroxide (0.5 mL, 0.25 mmol, 0.5 M) was 
stirred at room temperature for 10 min. Water was added and 
THF was removed under reduced pressure. The resulting aqueous 
solution was washed with diethyl ether (×2) and the aqueous 
extract was treated with Amberlite IR-120 until pH 6. The resin 80 
was filtered off and washed with Milli-Q water. The filtrate and 
the washings were lyophilised to give acid 5a (25 mg, 77%) as a 
yellow solid. Mp: 197199 ºC; []D20 = –48.2º (c 1.0 in MeOH); 
H (250 MHz; CD3OD): 7.757.61 (5 H, m, 5×ArH), 7.37 (2 H, 
m, 2×ArH), 7.02 (1 H, d, J = 16.3 Hz, ArCH=CH), 6.89 (1 H, d, J 85 
= 16.3 Hz, ArCH=CH), 5.80 (1 H, s, H-2), 4.36 (1 H, d, J = 3.3 
Hz, H-4), 3.96 (1 H, m, H-5) and 2.17 (2 H, m, CH2); C (63 
MHz; CD3OD): 180.7 (C), 138.7 (C), 136.4 (C), 135.2 (C), 134.5 
(C), 134.0 (CH), 130.9 (CH), 130.4 (CH), 129.2 (CH), 129.0 
(CH), 128.6 (CH), 127.6 (CH), 127.3 (CH), 126.8 (CH), 124.5 90 
(CH), 74.3 (C), 71.6 (CH), 68.8 (CH) and 35.9 (CH2); max 
(KBr)/cm-1 3410 (OH) and 1651 (CO); MS (ESI) m/z = 325 





trihydro-xycyclohex-2-ene-1-carboxylic acid (5b) 
The experimental procedure used was the same as for acid 5a 
utilizing lactone 14b (22.8 mg, 0.07 mmol). Yield = 18.4 mg 
(79%). Yellow solid. Mp: 184185 ºC; []D20 = –41.6º (c 1.0 in 100 
MeOH); H (250 MHz; CD3OD): 7.67 (2 H, m, 2×ArH), 7.22 (4 
H, m, 3×ArH+ArCH=CH), 6.63 (1 H, d, J = 16.0 Hz, 
ArCH=CH), 5.86 (1 H, s, H-2), 4.24 (1 H, d, J = 4.5 Hz, H-4), 
3.99 (1 H, m, H-5) and 2.14 (2 H, m, CH2); C (63 MHz; 
CD3OD): 178.8 (C), 144.6 (C), 141.7 (CH), 140.3 (C), 140.2 (C), 105 
131.5 (C), 131.1 (CH), 125.9 (CH), 125.5 (CH), 124.7 (CH), 
124.5 (CH), 123.0 (CH), 123.1 (CH), 71.4 (C), 71.1 (CH), 37.9 
(CH2) and 30.7 (CH); max (KBr)/cm
-1 3435 (OH), 1639 (CO); 
MS (ESI) m/z = 331 (MH+); HRMS (ESI) calcd for C17H15O5S 
(MH+): 331.0635, found 331.0634. 110 
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carbolactone (15c) 
A suspension of alkene 13a (115 mg, 0.22 mmol) and 
Rosemund’s catalyst (106 mg, 5% on weight) in a mixture of 
50% THF/methanol (10 mL) was stirred under hydrogen 
atmosphere at room temperature for 12 h. The mixture was 5 
filtered over Celite and the residue was washed with methanol. 
The filtrate and washings were evaporated. The obtained residue 
was purified by flash chromatography on silica gel, eluting with 
(1:2) dichloromethane/hexanes to yield naphthyl derivative 15a 
(89 mg, 75%) and compound 15c (23 mg, 20%). Data for 15a: 10 
White foam. []D20 = 6.5º (c 1.0 in CHCl3); H (250 MHz; 
CDCl3): 7.867.80 (3 H, m, 3×ArH), 7.62 (1 H, br s, ArH), 
7.567.45 (2 H, m, 2×ArH), 7.33 (1 H, dd, J = 8.4 and 1.6 Hz, 
ArH), 5.81 (1 H, s, H-2), 4.53 (1 H, m, H-5), 4.11 (1H, d, J = 3.1 
Hz, H-4), 3.002.75 (3 H, m, CH2+CHH), 2.522.35 (3 H, m, 15 
CH2+CHH), 0.99 (9 H, s, C(CH3)3), 0.96 (9 H, s, C(CH3)3), 0.21 
(3 H, s, CH3), 0.18 (6 H, s, 2×CH3) and 0.15 (3 H, s, CH3); C (63 
MHz; CDCl3): 176.2 (C), 138.6 (C), 138.4 (C), 133.7 (C), 132.1 
(C), 131.4 (CH), 128.1 (CH), 127.6 (CH), 127.6 (CH), 127.0 
(CH), 126.5 (CH), 126.0 (CH), 125.3 (CH), 76.0 (CH), 74.8 (C), 20 
68.0 (CH), 37.3 (CH2), 33.9 (CH2), 33.5 (CH2), 25.7 
(2×C(CH3)3), 18.1 (2×C(CH3)3), 3.0 (2×CH3) and 4.5 
(2×CH3); max (film)/cm
-1 1799 (C=O); MS (ESI) m/z = 561 
(MNa+); HRMS (ESI) calcd for C31H46O4Si2Na (MNa
+): 
561.2829, found 561.2823. Data for 15c: Colorless oil. []D20 = 25 
3.2º (c 1.0 in CHCl3); H (250 MHz; CDCl3): 7.09 (1 H, s, ArH), 
6.99 (1 H, d, J = 7.9 Hz, ArH), 6.86 (1 H, m, ArH), 5.71 (1 H, s, 
H-2), 4.48 (1 H, m, H-5), 4.04 (1 H, d, J = 3.1 Hz, H-4), 2.74 (7 
H, m, 3×CH2+CHH), 2.33 (3 H, m, CH2+CHH), 1.79 (4 H, m, 
2×CH2), 0.93 (9 H, s, C(CH3)3), 0.92 (9 H, s, C(CH3)3), 0.17 (3 30 
H, s, CH3), 0.16 (3 H, s, CH3), 0.15 (3 H, s, CH3) and 0.13 (3 H, 
s, CH3); C (63 MHz; CDCl3): 176.2 (C), 138.7 (C), 138.1 (C), 
137.2 (C), 134.9 (C), 131.3 (CH), 129.3 (CH), 129.2 (CH), 125.5 
(CH), 76.1 (CH), 74.8 (C), 67.9 (CH), 37.4 (CH2), 33.8 (CH2), 
33.5 (CH2), 29.5 (CH2), 29.2 (CH2), 25.8 (C(CH3)3), 25.8 35 
(C(CH3)3), 25.7 (3×CH3), 23.4 (CH2), 23.4 (CH2), 18.0 
(2×C(CH3)3), 2.9 (2×CH3), 4.4 (CH3) and 4.5 (CH3); max 
(film)/cm-1 1799 (CO); MS (ESI) m/z = 565 (MNa+); HRMS 
(ESI) calcd for C31H50O4Si2Na (MNa
+): 561.3140, found 
561.3128. 40 
 
Reduction of 13a with Raney-Ni 
To a stirred solution of alkene 13a (932 mg, 1.74 mmol) in 50% 
MeOH/THF (20 mL) was treated with an aqueous suspension of 
Raney-Ni (aprox. 0.24 equivalents). The resulting suspension was 45 
deoxygenated and was stirred under hydrogen atmosphere at 
room temperature for 2.5 h. The mixture was filtered over Celite 
and the residue was washed with methanol. The filtrate and 
washings were evaporated. The obtained residue was purified by 
flash chromatography on silica gel, eluting with (5:95) 50 




The experimental procedure used was the same as for compound 55 
15a using Rosemund´s catalyst and utilizing alkene 13b (115.8 
mg, 0.21 mmol). Yield = 65.2 mg (56%). Colorless oil. []D20 = –
88.3º (c 1.0 in CHCl3); H (250 MHz; CDCl3): 7.777.65 (2 H, m, 
2×ArH), 7.347.22 (2 H, m, 2×ArH), 6.98 (1 H, s, ArH), 5.78 (1 
H, s, 1H, H-2), 4.48 (1 H, m, H-5), 4.07 (1 H, d, J = 3.1 Hz, H-4), 60 
3.073.00 (2 H, m, CH2), 2.47 (2 H, m, CH2), 2.33 (2 H, m, 
CH2), 0.93 (9 H, s, C(CH3)3), 0.90 (9 H, s, C(CH3)3), 0.18 (3 H, s, 
SiCH3), 0.15 (3 H, s, SiCH3), 0.12 (3 H, s, SiCH3) and 0.09 (3 H, 
s, SiCH3); C (63 MHz; CDCl3): 176.0 (C), 144.9 (C), 137.7 (C), 
131.7 (CH), 128.5 (C), 124.3 (CH), 123.7 (CH), 123.0 (CH), 65 
122.3 (CH+C), 121.1 (CH), 76.1 (CH), 74.9 (C), 68.2 (CH), 37.3 
(CH2), 33.5 (CH2), 28.9 (CH2), 25.8 (2×C(CH3)3), 18.1 
(2×C(CH3)3), 2.9 (2×CH3), and 4.4 (2×CH3); max (film)/cm
-1 
1799 (CO); MS (ESI) m/z = 567 (MNa+); HRMS (ESI) calcd for 
C29H44O4SSi2Na (MNa




The experimental procedure used was the same as for diol 14a 
using silyl ether 15a (89 mg, 0.16 mmol). Yield = 39 mg (79%). 75 
White foam. []D20 = 89.6º (c 1.0 in MeOH); H (250 MHz; 
CD3OD): 7.767.69 (3 H, m, 3×ArH), 7.53 (1 H, br s, ArH), 7.37 
(2 H, m, 2×ArH), 7.25 (1 H, dd, J = 8.4 and 1.6 Hz, ArH), 5.71 
(1 H, s, H-2), 4.59 (1 H, m, H-5), 4.05 (1 H, d, J = 2.9 Hz, H-4), 
2.922.79 (2 H, m, CH2), 2.552.42 (2 H, m, CH2) and 2.28 (2 H, 80 
m, CH2); C (63 MHz; CD3OD): 179.0 (C), 140.6 (C), 140.1 (C), 
135.1 (CH), 133.5 (C), 131.3 (CH), 128.9 (CH), 128.5 (2×CH), 
128.2 (CH), 127.5 (CH), 126.8 (CH), 126.2 (CH), 77.9 (CH), 
73.9 (C), 67.6 (CH), 37.4 (CH2) and 34.8 (2×CH2); max 
(KBr)/cm-1 3448 (OH) and 1776, 1761 and 1726 (CO); MS (ESI) 85 
m/z = 333 (MNa+); HRMS (ESI) calcd for C19H18O4Na (MNa
+): 
333.1097, found 333.1226. 
 
(1R,4R,5R)-3-(2-(Benzo[b]thiophen-2-yl)ethyl)-1,4-dihydroxy-
cyclohex-2-en-1,5-carbolactone (16b) 90 
The experimental procedure used was the same as for diol 14a 
utilizing silyl ether 15b (65 mg, 0.12 mmol). Yield = 22 mg 
(60%). White foam. []D20 = 78.4º (c 1.0 in MeOH); H (250 
MHz; CD3OD): 7.72 (1 H, m, ArH), 7.64 (1 H, m, ArH), 
7.117.28 (3 H, m, 3×ArH), 5.76 (1 H, s, H-2), 4.60 (1 H, m, H-95 
5), 4.01 (1 H, d, J = 3.1 Hz, H-4), 3.103.02 (1 H, m, CHH), 
2.622.52 (3 H, m, CH2+CHH) and 2.26 (2 H, m, CH2); C (63 
MHz; CD3OD): 179.7 (C), 146.5 (C), 141.8 (C), 140.4 (C), 131.0 
(CH), 129.8 (CH), 125.6 (CH), 125.0 (CH), 124.4 (CH), 123.4 
(CH+C), 78.4 (CH), 74.4 (C), 68.0 (CH), 37.9 (CH2), 35.0 (CH2) 100 
and 29.9 (CH2); max (film)/cm
-1 3417 (OH), 1776 and 1770 
(CO); MS (ESI) m/z = 339 (MNa+); HRMS (ESI) calcd for 
C17H16O4SNa (MNa




The experimental procedure used was the same as for diol 14a 
utilizing ether 15c (118 mg, 0.23 mmol). Yield: 65 mg (90%). 
White solid. Mp: 155.6156.4 ºC; []D20 = –15.1º (c 1.0 in 
MeOH); H (250 MHz; CD3OD): 7.00 (1 H, s, ArH), 6.906.76 110 
(2 H, m, 2×ArH), 5.67 (1 H, s, H-2), 4.59 (1 H, m, H-4), 4.03 (1 
H, m, H-5), 2.68 (7 H, m, 3×CH2+CHH), 2.29 (3 H, m, 
2×CH2+CHH) and 1.761.73 (4 H, m, 2×CH2); C (63 MHz; 
CD3OD): 179.0 (C), 140.7 (C), 139.4 (C), 137.8 (C), 135.4 (C), 
131.1 (CH), 130.0 (2×CH), 126.6 (CH), 77.9 (CH), 73.9 (C), 67.4 115 
(CH), 37.4 (CH2), 35.1 (CH2), 34.3 (CH2), 30.2 (CH2), 30.0 
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(CH2), 24.5 (CH2) and 24.4 (CH2); max (film)/cm
-1 3409 (OH) 
and 1764 (CO); MS (ESI) m/z = 337 (MNa+); HRMS (ESI) calcd 
for C19H22O4Na (MNa
+): 337.1410, found 337.1414. 
 
(1R,4R,5R)-1,4-Dihydroxy-3-(2-(naphth-2-yl)ethyl)cyclohex-2-5 
ene-1-carboxylic acid (6a) 
The experimental procedure used was the same as for acid 5a 
utilizing lactone 16a (24.3 mg, 0.08 mmol). Yield = 22 mg 
(85%). White solid. Mp: 120122 ºC; []D20 = 8.3º (c 1.0 in 
MeOH); H (250 MHz; CD3OD): 7.797.73 (3 H, m, 3×ArH), 10 
7.65 (1 H, br s, ArH), 7.437.35 (3 H, m, 3×ArH), 5.52 (1 H, s, 
H-2), 3.973.88 (2 H, m, H-4+H-5), 3.063.98 (1 H, m, CHH), 
2.912.82 (1 H, m, CHH), 2.752.68 (1 H, m, CHH), 2.492.41 
(1 H, m, CHH) and 2.07 (2 H, m, CH2); C (63 MHz; CD3OD): 
178.3 (C), 145.0 (C), 140.8 (C), 135.1 (C), 133.5 (C), 128.8 15 
(CH), 128.5 (2xCH), 128.3 (CH), 127.4 (CH), 126.8 (CH), 126.1 
(CH), 125.0 (CH), 74.9 (CH), 74.2 (C), 71.1 (CH), 40.3 (CH2), 
35.7 (CH2) and 35.4 (CH2); max (film)/cm
-1 3435 (OH) and 1720 
(CO); MS (ESI) m/z = 327 (MH+); HRMS (ESI) calcd for 
C19H19O5 (MH
+): 327.1227, found 327.1243. 20 
 
(1R,4R,5R)-3-(2-(Benzo[b]thiophen-2-yl)ethyl)-1,4-dihydroxy-
cyclohex-2-ene-1,5-carboxylic acid (6b) 
The experimental procedure used was the same as for acid 5a 
utilizing lactone 16b (40 mg, 0.13 mmol). Yield = 36 mg (83%). 25 
White solild. Mp: 107108 ºC; []D20 = 3.6º (c1.0 in MeOH); H 
(250 MHz; CD3OD): 7.72 (1 H, d, J = 7.0 Hz, ArH), 7.63 (1 H, d, 
J = 7.0 Hz, ArH), 7.257.12 (3 H, m, 3×ArH), 5.43 (1 H, s, H-2), 
3.87 (2 H, m, H-5+H-4), 3.08 (1 H, m, CHH), 2.60 (1 H, m, 
CHH) and 2.09 (4 H, m, 2×CH2); C (63 MHz; CD3OD): 186.1 30 
(C), 146.7 (C), 141.7 (C), 140.7 (C), 140.0 (CH), 131.7 (C), 
125.0 (CH), 124.5 (CH), 123.8 (CH), 122.9 (CH), 122.0 (CH), 
78.0 (CH), 74.0 (C), 68.0 (CH), 40.6 (CH2), 35.3 (CH2) and 30.0 
(CH2); max (KBr)/cm
-1 3419 (OH) and 1778 (CO); MS (ESI) m/z 
= 333 (MH+); HRMS (ESI) calcd for C17H17O5S (MH
+): 35 
333.0791, found 333.0804. 
 
(1R,4R,5R)-1,4,5-Trihydroxy-3-(2-(5,6,7,8-tetrahydronaphth-
2-yl)ethyl)cyclohex-2-ene-1-carboxylic acid (6c) 
The experimental procedure used was the same as for acid 5a 40 
utilizing lactone 16c (34.5 mg, 0.11 mmol). Yield = 31.2 mg 
(85%). Mp: 127128 ºC; []D20 = 1.2º (c 1.0 in MeOH); H (400 
MHz; CD3OD): 6.90 (2 H, m, 2×ArH), 6.87 (1 H, m, ArH), 5.45 
(1 H, s, H-2), 3.89 (2 H, m, H-5+H-4), 2.782.74 (1 H, m, CHH), 
2.71 (4 H, m, 2×CH2), 2.632.57 (2 H, m, CH2), 2.29 (1H, m, 45 
CHH), 2.05 (2 H, m, CH2), and 1.77 (4 H, m, 2×CH2); C (63 
MHz; CD3OD): 178.4 (C), 145.2 (C), 140.2 (C), 137.8 (C), 135.3 
(C), 122.9 (2×CH), 126.6 (CH), 124.7 (CH), 74.8 (CH), 74.3 (C), 
71.0 (CH), 40.3 (CH2), 36.0 (CH2), 34.9 (CH2), 30.4 (CH2), 30.0 
(CH2), 24.6 (CH2), and 24.5 (CH2); max (KBr)/cm
-1 3427 (OH), 50 
1701 (CO); MS (ESI) m/z = 331 (MH+); HRMS (ESI) calcd for 
C19H23O5 (MH
+): 331.1540, found 331.1543. 
 
2-Vinylbenzo[b]thiophene (17b) 
A Shlenck tube was charged with 2-bromobenzothiophene 55 
(8b)[10] (250 mg, 1.17 mmol), vinylboronic acid pinacol ester (0.3 
mL, 1.73 mmol), Pd(PPh3)4 (67 mg, 0.06 mmol), aqueous K2CO3 
(3.45 mL, 1.1 M) and dioxane (10 mL). The resulting solution 
was heated at 100 ºC for 5 h. After cooling to room temperature, 
the reaction mixture was diluted with diethyl ether and water. The 60 
organic layer was separated and the aqueous phase was extracted 
with diethyl ether (×3). The combined organic extracts were dried 
(anh. Na2SO4), filtered and concentrated under reduced pressure. 
The residue was purified by flash chromatography on silica gel, 
eluting with (3:97) diethyl ether/hexanes to give 2-65 
vinylbenzo[b]thiophene (17b)[11] (180 mg, 96%). 
 
Preparation of 15a by B-alkyl Suzuki cross-coupling 
a) Preparation of borane 18a: A solution of 9-BBN-H (5.7 mL, 
2.85 mmol, ca 0.5 M in THF) was added to a flamed round-70 
bottom flask under argon. After cooling to 0 ºC, 2-
vinylnaphthalene (17a) (200 mg, 1.29 mmol) was added. The 
mixture was warmed up slowly to room temperature and stirred 
for 3 h to give a solution of borane 18a.  
b) B-alkyl Suzuki cross-coupling: To the borane solution obtained 75 
above, a solution of triflate 12[2c] (200 mg, 0.37 mmol) in THF (4 
mL), PdCl2(dppf) (12.3 mg, 0.02 mmol) and aqueous K3PO4 
(0.83 mL, 0.83 mmol, 1 M) were added. The resultant solution 
was heated at 70 ºC for 4 h under argon. After cooling to room 
temperature, the solution was diluted with diethyl ether and 80 
water. The organic layer was separated and the aqueous phase 
was extracted with diethyl ether (×2). The combined organic 
extracts were dried (Na2SO4), filtered and concentrated under 
reduced pressure. The residue was purified by flash 
chromatography on silica gel, eluting with (5:95) diethyl ether-85 
hexanes, to give compound 15a (156 mg, 80%). 
 
Trimethyl(3-(naphth-2-yl)prop-1-ynyl)silane (19a) 
A two necks round bottom flask equipped with a condenser and a 
pressure compensated addition funnel was charged with 90 
magnesium turnings (141 mg, 5.82 mmol) and a few iodine 
pellets. The system was flamed under vacuum and cooled under 
argon atmosphere. Dry THF (3 mL) was added to the round 
bottom flask and the compensated addition funnel was charged 
with a solution of 2-bromonaphthalene (8a) (1 g, 4.85 mmol) in 95 
dry THF (5 mL). This solution was slowly added to the 
suspension, which was heated under reflux for 2 h. The reaction 
mixture was cooled to room temperature and then it was treated 
with a solution of 3-bromoprop-1-ynyl)trimethylsilane (0.9 mL, 
7.2 mmol) in dry THF (3 mL). The reaction mixture was heated 100 
under reflux for 2 h and then cooled to room temperature. 
Saturated NH4Cl was added and the organic layer was separated. 
The aqueous phase was extracted with dichloromethane (×2). The 
combined organic extracts were dried (anh. Na2SO4), filtered and 
concentrated under reduced pressure. Purification by flash 105 
chromatography on silica gel, using hexanes as eluent, gave 
alkyne 19a (621 mg, 54%) as a white solid. Mp: 6163 ºC; H 
(400 MHz; CDCl3): 7.857.80 (4 H, m, 4×ArH), 7.507.44 (3 H, 
m, 3×ArH), 3.82 (2 H, s, CH2) and 0.24 (9 H, s, 3×CH3); C (100 
MHz; CDCl3): 133.8 (C), 133.5 (C), 132.3 (C), 128.1 (CH), 127.6 110 
(2×CH), 126.4 (CH), 126.2 (CH), 126.1 (CH), 125.5 (CH), 104.2 




(3-(Benzo[b]thiophen-3-yl)prop-1-ynyl)trimethylsilane (19d) 115 
The experimental procedure used was the same as for alkyne 19a 
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utilizing 3-bromobenzo[b]thiophene (8d) (1 g, 4.7 mmol) and (3-
bromoprop-1-ynyl)trimethylsilane (0.9 mL, 5.6 mmol). Yield = 
791 mg (69%). White solid. H (250 MHz; CDCl3): 7.907.86 (1 
H, m, ArH), 7.767.74 (1 H, m, ArH), 7.457.37 (3 H, m, ArH), 
3.81 (2 H, d, J = 1.25 Hz, CH2) and 0.26 (9 H, s, 3×CH3); C (63 5 
MHz; CDCl3): 140.6 (C), 137.9 (C), 130.6 (C), 124.3 (CH), 123.9 
(CH), 123.0 (CH), 122.9 (CH), 121.3 (CH), 102.9 (C), 87.3 (C), 
20.2 (CH2) and 0.1 (3×CH3); max (KBr)/cm
-1 2179 (C≡C); MS 
(CI) m/z = 245 (MH+). 
 10 
2-(Propa-1,2-dienyl)naphthalene (21a) 
A stirred solution of silyl ether 19a (30 mg, 0.13 mmol) in 
methanol (1.5 mL) at 0 ºC was treated with potassium carbonate 
(17 mg, 0.13 mmol). The ice bath was removed and the resulting 
mixture was stirred for 1 h. The reaction mixture was partitioned 15 
in water and diethyl ether. The organic layer was separated and 
the aqueous phase was extracted with diethyl ether (×2). The 
combined organic extracts were dried (anh. Na2SO4), filtered and 
concentrated under reduced pressure. The residue was purified by 
flash chromatography on silica gel, eluting with (10:90) diethyl 20 
ether/hexanes to give allene 21a (20 mg, 91%) as a white solid. 
Mp: 55.756.3 ºC; H (250 MHz; CDCl3): 7.437.36 (3 H, m, 
3×ArH), 7.26 (1 H, s, ArH), 7.137.02 (3 H, m, 3×ArH), 5.96 (1 
H, t, J = 6.25 Hz, CH) and 4.83 (2 H, d, J = 5.0 Hz, CH2); C (75 
MHz; CDCl3): 210.5 (C), 133.8 (C), 132.7 (C), 131.5 (C), 128.4 25 
(CH), 127.9 (CH), 127.8 (CH), 126.4 (CH), 125.8 (CH), 125.5 
(CH), 124.8 (CH), 94.5 (CH) and 79.2 (CH2); MS (CI) m/z = 167 
[MH+]; HRMS (CI) calcd for C13H11 (MH




A stirred solution of silyl silane 19a (600 mg, 2.5 mmol) in 
ethanol (11 mL) was treated with a solution of AgNO3 in (2.3:1) 
EtOH/H2O (11 mL, 0.35 M). The resultant solution was stirred on 
the dark at room temperature for 2 h during which time a white 35 
solid was formed. An aqueous solution of potassium cyanide (3.3 
mL, 7.6 M) was then added and the reaction mixture was stirred 
until disappearance of the white precipitate. Diethyl ether was 
added and the aqueous layer was separated. The organic extract 
was washed with brine, dried (anh. Na2SO4), filtered and 40 
concentrated under reduced pressure. The residue was purified by 
flash chromatography on silica gel, using hexanes as eluent, to 
give alkyne 20a (297 mg, 72%) as a white solid. Mp: 5253 ºC; 
H (250 MHz; CDCl3): 7.847.81 (4 H, m, 4×ArH), 7.517.44 (3 
H, m, 3×ArH), 3.79 (2 H, d, J = 1.5 Hz, CH2) and 2.27 (1 H, t, J 45 
= 1.8 Hz, C≡CH); C (63 MHz; CDCl3): 133.4 (2×C), 132.3 (C), 
128.2 (CH), 127.6 (2×CH), 126.3 (CH), 126.2 (CH), 126.1 (CH), 
125.6 (CH), 81.9 (C), 70.7 (CH) and 24.9 (CH2); max (KBr)/cm
-
1 3282 (C≡C) cm-1. MS (CI) m/z = 167 (MH+); HRMS (CI) calcd 
for C13H11 (MH
+): 167.0861, found 167.0858. 50 
 
3-(Prop-2-ynyl)benzo[b]thiophene (20d) 
The experimental procedure used was the same as for alkyne 20a 
utilizing silyl ether 19d (1.6 g, 6.5 mmol). Yield = 657 mg (61%). 
Yellow oil. H (250 MHz; CDCl3): 8.00 (1 H, m, ArH), 7.91 (1 H, 55 
m, ArH), 7.79 (2 H, m, 2×ArH), 7.58 (1 H, s, ArH), 3.79 (2 H, 
dd, J = 2.8 and 1.3 Hz, CH2) and 2.29 (1 H, t, J = 2.8 Hz, C≡CH); 
C (63 MHz; CDCl3): 140.1 (C), 138.5 (C), 131.3 (C), 124.6 
(CH), 124.3 (CH), 123.2 (CH), 122.8 (CH), 121.2 (CH), 80.6 
(CH), 70.6 (C) and 18.8 (CH2); max (film)/cm
-1 3293 (C≡C); MS 60 
(CI) m/z = 173 (MH+); HRMS (CI) calcd for C11H9S (MH
+): 
173.0425, found 173.0430. 
 
2-Allylnaphthalene (22a) 
The experimental procedure used was the same as for alkyne 19a 65 
utilizing 2-bromonaphthalene (8a) (200 mg, 0.96 mmol) and allyl 
bromide (0.09 mL, 1 mmol). Yield = 158 mg (99%). Colorless 
oil. H (300 MHz; CDCl3): 7.917.85 (3 H, m, 3×ArH), 7.71 (1 
H, s, ArH), 7.587.40 (3 H, m, 3×ArH), 6.236.07 (1 H, m, 
CH=CH2), 5.285.19 (2 H, m, CH=CH2) and 3.63 (2 H, d, J = 7.8 70 
Hz, CH2); C (75 MHz; CDCl3): 137.5 (C), 137.3 (CH), 133.6 
(C), 132.1 (C), 127.9 (CH), 127.6 (CH), 127.4 (CH), 127.3 (CH), 
126.6 (CH), 125.9 (CH), 125.2 (CH), 116.0 (CH2) and 40.3 
(CH2); MS (CI) m/z = 169 (MH
+); HRMS (CI) calcd for C13H13 
(MH+): 169.1017, found 169.1023. 75 
 
3-Allylbenzo[b]thiophene (22d) 
The experimental procedure used was the same as for 2-
allylnaphthalene (22a) utilizing 3-bromobenzo[b]thiophene (8d) 
(300 mg, 1.4 mmol). Yield = 218 mg (89%). Colorless oil. H 80 
(250 MHz; CDCl3): 8.057.86 (2 H, m, 2×ArH), 7.587.38 (3 H, 
m, 3×ArH), 6.286.15 (1 H, m, CH=CH2), 5.365.27 (2 H, m, 
CH=CH2) and 3.75 (2 H, m, CH2); C (63 MHz; CDCl3): 140.5 
(C), 138.8 (C), 135.5 (CH), 134.5 (C), 124.2 (CH), 123.8 (CH), 
122.8 (CH), 122.1 (CH), 121.8 (CH), 116.6 (CH2) and 33.0 85 
(CH2); MS (CI) m/z = 175 (MH
+); HRMS (CI) calcd for C11H11S 
(MH+): 175.0581, found 175.0582. 
 
(1R,4R,5R)-1,4-Di(tert-butyldimethylsilyloxy)-3-(3-(naphth-2-
yl)prop-1-ynyl)cyclohex-2-en-1,5-carbolactone (24a) 90 
A Shlenck tube was charged with triflate 12[2c] (100 mg, 0.19 
mmol) and dry THF (9.5 mL). CuI (7.6 mg, 0.04 mmol), 
Pd(PPh3)4 (45 mg, 0.04 mmol), 2-(prop-2-ynyl)naphthalene (20a) 
(158 mg, 0.95 mmol) and piperidine (0.25 mL, 2.47 mmol) were 
added. The resultant solution was deoxygenated and heated at 40 95 
ºC for 4 h. After cooling to room temperature, the reaction 
mixture was diluted with diethyl ether and water. The organic 
layer was separated and the aqueous phase was extracted with 
diethyl ether (×2). The combined organic extracts were washed 
with saturated solution of sodium bicarbonate (×2), dried (anh. 100 
Na2SO4), filtered and concentrated under reduced pressure. The 
residue was purified by flash chromatography on silica gel, 
eluting with a gradient of dichloromethane-hexanes (5:95 to 
35:65), to give naphthyl derivative 24a (102 mg, 98%) as an 
orange foam. []D20 = 136º (c 1.0 in CHCl3); H (250 MHz; 105 
CDCl3): 7.847.77 (4 H, m, 4×ArH), 7.497.40 (3 H, m, 3×ArH), 
6.27 (1 H, s, H-2), 4.49 (1 H, m, H-5), 4.17 (1 H, d, J = 3.3 Hz, 
H-4), 3.88 (2 H, s, CH2Ar), 2.38 (2 H, m, CH2-6), 0.92 (9 H, s, 
C(CH3)3), 0.89 (9 H, s, C(CH3)3), 0.20 (3 H, s, SiCH3), 0.16 (3 H, 
s, SiCH3) and 0.12 (6 H, s, 2×SiCH3); C (63 MHz; CDCl3): 110 
175.0 (C), 140.7 (CH), 133.5 (C), 133.4 (C), 132.3 (C), 128.3 
(CH), 127.6 (CH), 127.6 (CH), 126.4 (CH), 126.3 (CH), 126.2 
(CH), 125.6 (CH), 127.8 (C), 89.5 (C), 80.4 (C), 75.8 (CH), 74.9 
(C), 68.2 (CH), 36.8 (CH2), 25.8 (CH2), 25.6 (2×C(CH3)3), 18.0 
(2×C(CH3)3), 3.1 (2×SiCH3), 4.6 (SiCH3) and 4.9 (SiCH3); 115 
max (KBr)/cm
-1 2225 (CC) and 1803 (CO) cm-1; MS (ESI) m/z 
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= 571 (MNa+); HRMS (ESI) calcd for C32H44Si2O4Na (MNa
+): 





The experimental procedure used was the same as for naphthyl 
derivative 24a using alkyne 20d (164 mg, 0.95 mmol) and triflate 
12[2c] (100 mg, 0.19 mmol). Yield = 100 mg (95%). Orange foam. 
[]D20 = 132º (c 1.0 in CHCl3); H (400 MHz; CDCl3): 7.87 (1 10 
H, m, ArH), 7.75 (1 H, m, ArH), 7.437.37 (2 H, m, 2×ArH), 
7.35 (1 H, s, ArH), 6.26 (1 H, d, J = 1.6 Hz, H-2), 4.48 (1 H, dd, J 
= 5.6 and 3.2 Hz, H-5), 4.14 (1 H, d, J = 3.2 Hz, H-4), 3.87 (2 H, 
s, CH2Ar), 2.40 (1 H, d, J = 10.8 Hz, H-6ax), 2.36 (1 H, ddd, J = 
10.8, 5.6 and 1.6 Hz, H-6eq), 0.93 (9 H, s, C(CH3)3), 0.88 (9 H, s, 15 
C(CH3)3), 0.20 (3 H, s, SiCH3), 0.16 (3 H, s, SiCH3), 0.09 (3 H, s, 
SiCH3) and 0.07 (3 H, s, SiCH3); C (100 MHz; CDCl3): 174.9 
(C), 140.9 (CH), 140.6 (C), 137.9 (C), 130.1 (C), 124.5 (CH), 
124.1 (CH), 123.2 (CH), 122.9 (CH), 122.6 (C), 121.3 (CH), 88.2 
(C), 80.2 (C), 75.8 (CH), 74.9 (C), 68.2 (CH), 36.8 (CH2), 25.6 20 
(2×C(CH3)3), 19.6 (CH2), 18.0 (2×C(CH3)3), 3.1 (2×SiCH3), 
4.7 (SiCH3) and 4.9 (SiCH3); max (KBr)/cm
-1 2227 (CC) and 
1803 (C=O); MS (CI) m/z = 555 (MH+); HRMS (CI) calcd for 
C30H42O4SSi2Na (MNa




The experimental procedure used was the same as for compound 
15a using alkyne 24a (168 mg, 0.30 mmol), Rosemund’s catalyst 
(150 mg) and 50% THF/methanol (6 mL). Purification by flash 30 
chromatography on silica gel, eluting with (30:70) 
dichloromethane/hexanes, gave saturated derivative 25a (166 mg, 
98%) as a colorless oil. []D20 = 49.1º (c 1.0 in MeOH); H (400 
MHz; CDCl3): 7.767.58 (3 H, m, 3×ArH), 7.47 (1 H, br s, ArH), 
7.457.39 (2 H, m, 2×ArH), 7.29 (2 H, dd, J = 1.6 and 8.4 Hz, 35 
2×ArH), 5.73 (1 H, d, J = 1.6 Hz, H-2), 4.45 (1 H, m, H-5), 4.00 
(1 H, d, J = 3.2 Hz, H-4), 2.85 (2 H, td, J = 1.6 and 7.2 Hz, 
CH2Ar), 2.31 (2 H, m, CH2), 2.06 (2 H, m, CH2), 1.83 (2 H, m, 
CH2), 0.92 (9 H, s, C(CH3)3), 0.85 (9 H, s, C(CH3)3), 0.18 (3 H, s, 
SiCH3), 0.14 (3 H, s, SiCH3), 0.09 (3 H, s, SiCH3) and 0.04 (3 H, 40 
s, SiCH3); C (100 MHz; CDCl3): 176.1 (C), 139.2 (C), 138.9 (C), 
133.6 (C), 132.0 (C), 130.7 (CH), 128.0 (CH), 127.6 (CH), 127.4 
(CH), 127.2 (CH), 126.5 (CH), 125.9 (CH), 125.1 (CH), 76.0 
(CH), 74.7 (C), 67.7 (CH), 37.2 (CH2), 35.6 (CH2), 31.4 (CH2), 
28.5 (CH2), 25.6 (2×C(CH3)3), 18.0 (C(CH3)3), 17.8 (C(CH3)3), 45 
3.0 (2×SiCH3), 4.6 (SiCH3) and 4.8 (SiCH3); max (film)/cm
-1 
1799 (CO); MS (ESI) m/z = 553 (MH+); HRMS (ESI) calcd for 
C32H49Si2O4 (MH
+): 553.3164, found 553.3145. 
 (1R,4R,5R)-3-(3-(Benzo[b]thiophen-3-yl)propyl)-1,4-di(tert-
butyldime-thylsilyloxy)cyclo-hex-2-en-1,5-carbolactone (25d) 50 
The experimental procedure used was the same as for saturated 
derivative 15a utilizing alkyne 24d (60 mg, 0.11 mmol). Yield = 
60 mg (98%). Yellow oil. []D20 = 86.4º (c 1.0 in CHCl3); H 
(250 MHz; CDCl3): 7.86 (1 H, d, J = 7.3 Hz, ArH), 7.72 (1 H, d, 
J = 8.2 Hz, ArH), 7.38 (2 H, m, 2×ArH), 7.07 (1 H, s, ArH), 5.76 55 
(1 H, s, H-2), 4.48 (1 H, m, H-5), 4.01 (1 H, d, J = 3.0 Hz, H-4), 
2.85 (2 H, t, J = 7.3 Hz, CH2Ar), 2.32 (2 H, m, CH2-6), 2.12 (2 H, 
m, CH2), 1.88 (2 H, m, CH2), 0.93 (9 H, s, C(CH3)3), 0.87 (9 H, s, 
C(CH3)3), 0.19 (3 H, s, SiCH3), 0.14 (3 H, s, SiCH3), 0.10 (3 H, s, 
SiCH3) and 0.04 (3 H, s, SiCH3); C (63 MHz; CDCl3): 176.1 (C), 60 
140.5 (C), 138.8 (C), 138.7 (C), 136.1 (C), 130.8 (CH), 124.1 
(CH), 123.9 (CH), 122.9 (CH), 121.6 (CH), 121.4 (CH), 75.9 
(CH), 74.7 (C), 67.7 (CH), 37.2 (CH2), 31.2 (CH2), 28.0 (CH2), 
26.6 (CH2), 25.6 (2×C(CH3)3), 18.0 (C(CH3)3), 17.9 (C(CH3)3), 
1.0 (SiCH3), 3.0 (SiCH3), and 4.6 (SiCH3), 4.8 (SiCH3); max 65 




The experimental procedure used was the same as for diol 14a 70 
utilizing silyl ether 25a (38 mg, 0.07 mmol). Purification by flash 
chromatography on silica gel, eluting with (1:1:1) diethyl 
ether/acetone/hexanes, gave diol 26a (17 mg, 77%) as a white 
foam. []D20 = 151.4º (c1.0 in MeOH); Mp: 125128 ºC; H 
(400 MHz; CD3OD): 7.71 (3 H, m, 3×ArH), 7.53 (1 H, br s, 75 
ArH), 7.367.23 (3 H, m, 3×ArH), 5.74 (1 H, s, H-2), 4.56 (1 H, 
m, H-5), 3.98 (1 H, d, J = 4.0 Hz, H-4), 2.67 (2 H, t, J = 7.0 Hz, 
CH2Ar), 2.27 (2 H, m, CH2-6), 2.12 (2 H, m, CH2) and 1.81 (2 H, 
m, CH2); C (100 MHz; CD3OD): 179.3 (C), 141.2 (C), 140.7 
(C), 135.1 (C), 133.5 (C), 130.8 (CH), 128.9 (CH), 128.6 (CH), 80 
128.5 (CH), 128.3 (CH), 127.5 (CH), 126.9 (CH), 126.1 (CH), 
78.0 (CH), 74.0 (C), 67.6 (CH), 37.5 (CH2), 36.3 (CH2), 32.5 
(CH2) and 29.7 (CH2); max (KBr)/cm
-1 3431 (OH), 3290 (OH) 
and 1757 (CO); MS (ESI) m/z = 323 (MH+); HRMS (ESI) calcd 
for C20H19O4 (M-H




The experimental procedure used was the same as for diol 14a 
utilizing silyl ether 25d (85 mg, 0.15 mmol). Yield: 33 mg (67%). 90 
White solid. Mp: 156160 ºC. []D20 = 128.7º (c 1.0 in MeOH); 
H (500 MHz; CD3OD): 7.80 (1 H, d, J = 8.0 Hz, ArH), 7.70 (1 
H, d, J = 8.0 Hz, ArH), 7.357.27 (2 H, m, 2×ArH), 7.16 (1 H, s, 
ArH), 5.79 (1 H, s, H-2), 4.59 (1 H, m, H-5), 4.01 (1 H, d, J = 3.5 
Hz, H-4), 2.78 (2 H, m, CH2Ar), 2.322.27 (2 H, m, CH2-6), 95 
2.252.21 (2 H, m, CH2), 1.97 (1 H, m, CHH) and 1.861.77 (1 
H, m, CHH); C (63 MHz; acetone-d6): 178.6 (C), 141.3 (2×C), 
140.8 (C), 138.3 (C), 131.7 (CH), 126.0 (CH), 125.7 (CH), 124.5 
(CH), 123.5 (CH), 123.2 (CH), 78.0 (CH), 74.6 (C), 68.4 (CH), 
38.2 (CH2), 33.4 (CH2), 29.4 (CH2) and 28.4 (CH2); max 100 
(KBr)/cm-1 2952 (OH), 2929 (OH) and 1799 (CO); MS (ESI) m/z 
= 353 (MNa+); HRMS (ESI) calcd for C18H18O4SNa (MNa
+): 
353.0823, found 353.0818. 
 
(1R,4R,5R)-1,4,5-Trihydroxy-3-(3-(naphth-2-105 
yl)propyl)cyclohex-2-ene-1-carboxylic acid (7a) 
The experimental procedure used was the same as for acid 5a 
utilizing lactone 26a (30 mg, 0.09 mmol). Yield = 30 mg (94%). 
White solid. []D20 = 23.2º (c1.0 in MeOH); Mp: 154158 ºC; 
H (400 MHz; CD3OD): 7.67 (3 H m, 3×ArH), 7.54 (1 H, br s, 110 
ArH), 7.30 (3 H, m, 3×ArH), 5.38 (1 H, s, H-2), 3.81 (2 H, m, H-
5+H-4), 2.70 (2 H, m, CH2Ar), 2.34 (1 H, m, CHH) and 
2.061.75 (5 H, m, CHH+2×CH2); 
13C NMR (100 MHz, CD3OD) 
: 178.4 (C), 145.1 (C), 141.1 (C), 135.2 (C), 133.5 (C), 128.8 
(CH), 128.6 (CH), 128.4 (2×CH), 127.6 (CH), 126.8 (CH), 126.1 115 
(CH), 124.9 (CH), 74.7 (CH), 74.3 (C), 71.1 (CH), 40.5 (CH2), 
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36.3 (CH2), 33.1 (CH2) and 30.1 (CH2); max (KBr)/cm
-1 3390 
(OH) and 1718 (CO) cm-1. MS (ESI) m/z = 341 [MH]; HRMS 
(ESI) calcd for C20H21O5 [MH]: 341.1384, found 341.1384. 
 
(1R,4R,5R)-3-(3-(Benzo[b]thiophen-3-yl)propyl)-1,4,5-5 
trihydroxy-cyclohex-2-ene-1-carboxylic acid (7d) 
The experimental procedure used was the same as for acid 5a 
utilizing diol 26d (30 mg, 0.09 mmol). Yield = 26 mg (87%). 
White solid. Mp: 118119 ºC. []D20 = 34.1º (c 1.0, MeOH). 
1H 
NMR (400 MHz, CD3OD) : 7.82 (1 H, d, J = 8.0 Hz, ArH), 7.77 10 
(1 H, d, J = 7.2 Hz, ArH), 7.367.27 (2 H, m, 2×ArH), 7.21 (1 H, 
s, ArH), 5.47 (1 H, s, H-2), 3.913.84 (2 H, m, H-5+H-4), 
2.952.79 (2 H, m, CH2), 2.542.42 (1 H, m, CHH) and 
2.181.80 (5 H, m, 2×CH2+CHH); C (100 MHz; CD3OD): 178.8 
(C), 144.7 (C), 141.9 (C), 140.4 (C), 137.9 (C), 125.3 (CH), 15 
125.2 (CH), 124.9 (CH), 123.7 (CH), 122.8 (CH), 122.4 (CH), 
74.6 (CH), 74.4 (C), 71.1 (CH), 40.3 (CH2), 33.4 (CH2), 28.8 
(CH2) and 28.2 (CH2); max (KBr)/cm
-1 3367 (OH) and 1709 
(CO); MS (ESI) m/z = 347 (MH+); HRMS (ESI) calcd for 
C18H19O5S (MH
+): 347.0948, found 347.0955. 20 
 
Preparation of 25a by B-alkyl Suzuki cross-coupling 
a) Preparation of borane 23a: To a solution of 9-BBN-H (0.4 
mL, 0.20 mmol, ca 0.5 M in THF) in a flamed round-bottom 
flask under argon 2-allylnaphthalene (22a) (63 mg, 0.37 mmol) 25 
was added. The mixture was stirred for 12 h to give a solution of 
borane 23a.  
b) B-alkyl Suzuki cross-coupling: To the borane solution obtained 
above, K3PO4 (63 mg, 0.28 mmol), Pd(PPh3)4 (33 mg, 0.03 
mmol), dioxane (0.8 mL) and triflate 12[2c] (100 mg, 0.12 mmol) 30 
were added. The resultant solution was heated at 110 ºC for 12 h 
under argon. After cooling to room temperature, the solution was 
diluted with diethyl ether and water. The organic layer was 
separated and the aqueous phase was extracted with diethyl ether 
(×2). The combined organic extracts were dried (Na2SO4), 35 
filtered and concentrated under reduced pressure. The residue was 
purified by flash chromatography on silica gel, eluting with a 
gradient of dichloromethane-hexanes (10:90 to 40:60), to give 
compound 25a (73 mg, 70%). 
 40 
Preparation of 25d by B-alkyl Suzuki cross-coupling 
a) Preparation of borane 23d: To a solution of 9-BBN-H (0.44 
mL, 0.22 mmol, ca 0.5 M in THF) in a flamed round-bottom 
flask under argon 3-allylbenzo[b]thiophene (22d) (65 mg, 0.37 
mmol) was added. The mixture was stirred for 12 h to give a 45 
solution of borane 23d.  
b) B-alkyl Suzuki cross-coupling: To the borane solution obtained 
above, K3PO4 (84 mg, 0.38 mmol), Pd(PPh3)4 (32 mg, 0.03 
mmol), dioxane (0.8 mL), KBr (25 mg, 0.21 mmol) and triflate 
12[2c] (100 mg, 0.12 mmol) were added. The resultant solution 50 
was heated at 110 ºC for 12 h under argon. After cooling to room 
temperature, the solution was diluted with diethyl ether and 
water. The organic layer was separated and the aqueous phase 
was extracted with diethyl ether (×2). The combined organic 
extracts were dried (Na2SO4), filtered and concentrated under 55 
reduced pressure. The residue was purified by flash 
chromatography on silica gel, eluting with a gradient of 
dichloromethane-hexanes (10:90 to 40:60), to give compound 
25d (44 mg, 42%). 
 60 
Dehydroquinase Assays 
The enzyme was purified and assayed as described 
previously.[12,2d] 
 
Docking studies 65 
They were carried out using program GOLD 5.0.1[9] and the 
enzyme geometries found in the crystal structure of the binary 
complex DHQ2-Hp/4c (PDB code: 2WKS[5a]) and DHQ2-Mt/ 4c 
(PDB code: 2Y71[5b]) In the latter case, not solved residues 18-20 
were incorporated from the crystal structure of the fully resolved 70 
crystal structure of DHQ2-Mt in complex with (1R,2R,4S,5R)-
1,4,5-trihydroxy-2-(4-methoxybenzyl)-3-
oxocyclohexanecarboxylic acid (PDB code: 2XB8[7]) The 
receptor was used as a dimer. Water molecules were removed 
from all crystal structures with the expection of the water 75 
involved in the mechanism, which is located close to the carbonyl 
group of C3. Ligand geometries were minimized using the AM1 
Hamiltonian as implemented in the program Gaussian 09[13] and 
used as MOL2 files. Each ligand was docked in 25 independent 
genetic algorithm (GA) runs, and for each of these a maximum 80 
number of 100000 GA operations were performed on a single 
population of 50 individuals. Operator weights for crossover, 
mutation and migration in the entry box were used as default 
parameters (95, 95, and 10, respectively), as well as the hydrogen 
bonding (4.0 Å) and van der Waals (2.5 Å) parameters. The 85 
position of ligand 4c in both crystal structures was used to define 
the active-site and the radius was set to 7 Å. The “flip ring 
corners” flag was switched on, while all the other flags were off. 
The GOLD scoring function was used to rank the ligands in order 
to fitness. 90 
 
Molecular dynamics simulations 
Ligand minimization. Ligand geometries were first refined by 
means of the semi-empirical quantum mechanical program 
MOPAC[14] using the AM1 Hamiltonian and PRECISE stopping 95 
criteria, and further optimised using a restricted Hartree–Fock 
(RHF) method and a 6–31G(d) basis set, as implemented in the 
ab initio program Gaussian 09.[13] The resulting wavefunctions 
were used to calculate electrostatic potential-derived (ESP) 
charges employing the restrained electrostatic potential (RESP)[15 100 
] methodology, as implemented in the assisted model building 
with energy refinement (AMBER)[16] suite of programs. The 
missing bonded and non-bonded parameters were assigned, by 
analogy or through interpolation from those already present in the 
AMBER database (GAFF).[17,13] 105 
 
Generation and minimization of the DHQ2-ligand complexes. 
Simulations were carried out using the enzyme geometries found 
in the crystal structure of DHQ2-Mt in complex 4c (PDB code 
2Y71[5b]). Not solved residues 18-20 were incorporated from the 110 
crystal structure of the fully resolved crystal structure of DHQ2-
Mt in complex with (1R,2R,4S,5R)-1,4,5-trihydroxy-2-(4-
methoxybenzyl)-3-oxocyclo-hexanecarboxylic acid (PDB code: 
2XB8[7]). Taking into account that unfolding and refolding 
studies of DHQ2 have shown that the trimer[18] is the biological 115 
unit of the enzyme and on the basis of preliminary simulations on 
 
14  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
the monomer proving to be unstable under our simulation 
conditions, the trimer was used for these studies. Hydrogens were 
added to the protein using web-based PROPKA3.1 server,[19] 
which assigned protonation states to all titratable residues at the 
chosen pH of 7.0. However, δ and/or ε protonation was manually 5 
corrected for His102 (dual) of the active site due to the 
mechanistic considerations and on the basis of results from 
preliminary MD simulations. Molecular mechanics parameters 
from the ff03 and GAFF force fields, respectively, were assigned 
to the protein and the ligands using the LEaP module of AMBER 10 
10.0.[20] All terminal hydrogens were first minimizated in vacuo 
(2000 steps, half of them steepest descent, the other half 
conjugate gradient). Then, energy minimization using the implicit 
solvent GB model was carried out in stages, starting with ligand 
(1000 steps, half of them steepest descent, the other half 15 
conjugate gradient), protein side-chains (1000 steps, idem) and 
finally the entire complex (1000 steps, idem). A positional 
restraint force constant of 50 kcal mol-1 Å-2 to those unminimized 
atoms in each step was applied during all calculations. Thereafter 
each refined DHQ2-ligand complex was neutralized by addition 20 
of sodium ions and immersed in a truncated octahedron of TIP3P 
water molecules.[16,21,22] 
 
Simulations. MD simulations were performed using the AMBER 
10.0 suite of programs and Amber ff03 force field. Periodic 25 
boundary conditions were applied and electrostatic interactions 
were treated using the smooth particle mesh Ewald method 
(PME)[23] with a grid spacing of 1 Å. The cutoff distance for the 
non-bonded interactions was 9 Å. SHAKE algorithm[24] was 
applied to all bonds containing hydrogen, using a tolerance of 10-30 
5 Å and an integration step of 2.0 fs. Minimization was carried 
out in three steps, starting with the octahedron water hydrogens, 
followed by solvent molecules and sodium counterions and 
finally the entire system. The minimized system was heated at 
300 K (1 atm, 25 ps, a positional restraint force constant of 50 35 
kcal mol-1 Å-2). These initial harmonic restraints were gradually 
reduced to 5 kcal mol-1 Å-2 (10 steps) and the resulting systems 
were allowed to equilibrate further. MD with constraints of 5 kcal 
mol-1 Å-2 were carried out to all protein α-carbons of the two 
external subunits of the trimer and the beta sheets and alpha helix 40 
of the central subunit of the trimer for 10 ns (500 steps). System 
coordinates were collected every 2 ps for further analysis. Next, a 
slow-cooling MD simulation with constraints of 5 Kcal mol-1 Å-2 
was performed (6 steps until 273 K). Finally, minimization of the 
entire complexes was performed with constraints of 5 Kcal mol-1 45 
Å-2 
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